Connection

Kelly Hunt to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications Kelly Hunt has written about Receptor, ErbB-2.
Kelly Hunt
Connection Strength
0.128
Receptor, ErbB-2
  1. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. J Clin Oncol. 2017 Apr 01; 35(10):1049-1060.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.